Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin pre-treatment before elective cardiac surgery for postoperative atrial fibrillation
ACTRN12621000684820Phase 2Not yet recruiting
- Sponsor
- Flinders University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dapagliflozin in Atrial fibrillation (AFib), sponsored by Flinders University. Primary endpoints: Proportion of endocardial and epicardial electrograms showing endo-epicardial dissociation, Postoperative atrial fibrillation burden during inpatient stay and 1 more. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ACTRN12621000684820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000684820.